Infections in patients with lymphoproliferative diseases treated with brentuximab vedotin: SEIFEM multicentric retrospective study: Leukemia and Lymphoma

G. Marchesini, G. Nadali, D. Facchinelli, A. Candoni, C. Cattaneo, A. Cuccaro, R. Fanci, F. Farina, F. Lessi, A. Visentin, F. Marchesi, L. Prezioso, A. Spolzino, M.C. Tisi, F. Trastulli, L. Verga, M. Dargenio, A. Busca, L. Pagano, Italy for Sorveglianza Epidemiologica Infezioni nelle Emopatie (SEIFEM) Group

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)3002-3005
Number of pages4
JournalLeuk. Lymphoma
Volume61
Issue number12
DOIs
Publication statusPublished - 2020

Keywords

  • aciclovir
  • bendamustine
  • brentuximab vedotin
  • steroid
  • adult
  • aged
  • bacterial infection
  • bloodstream infection
  • Candida albicans
  • candidemia
  • clinical article
  • clinical evaluation
  • cohort analysis
  • cytomegalovirus infection
  • disease severity
  • Enterococcus faecium
  • Epstein Barr virus infection
  • female
  • fever
  • histopathology
  • Hodgkin disease
  • human
  • incidence
  • invasive aspergillosis
  • Italy
  • Letter
  • lung infection
  • lung lavage
  • lymphocytopenia
  • lymphoproliferative disease
  • male
  • microbiological examination
  • mixed infection
  • monotherapy
  • mortality rate
  • multicenter study (topic)
  • multidrug resistant bacterium
  • neutropenia
  • observational study
  • Pneumocystis jiroveci
  • Pneumocystis pneumonia
  • priority journal
  • Pseudomonas aeruginosa
  • retrospective study
  • Staphylococcus epidermidis
  • Staphylococcus hominis
  • systemic mycosis
  • virus infection
  • virus reactivation
  • X ray
  • x-ray computed tomography

Cite this